Meanwhile, referring to social media reports, the Chinese Embassy of Sri Lanka said the Bangladesh has not yet finalized their procurement agreement including pricing.

“We checked with Chinese Embassy in Dhaka as well as #Sinopharm group. Bangladesh Health Minister has clarified last week that their procurement agreement including pricing is not finalized yet. The fake news on social media has already disturbed their ongoing negotiation,” the Chinese Embassy said.

China to supply 1 billion vaccine doses overseas by year end - Global Times

Source: https://www.theedgemarkets.com/article/china-supply-1-billion-vaccine-doses-overseas-year-end-global-times#.YLoaa4Qn1UM.telegram

My remarks:
1. Wuhan Institute of Biological Products saya rasa satu lagi vaksin oleh Sinopharm, Sinopharm / WIBP2. WIBP tu ialah Wuhan Institute of Biological Products.

2. Yang dah lulus 7 Mei tu, Vaksin Sinopharm / BIBP1 vaccine was developed through a collaboration between the Chinese Center for Disease Control and Prevention (CDC) and the Beijing Institute of Biological Products (BIBP)/China National Biotec Group Company Limited (CNBG).

3. Kedua-duanya melibatkan CNBG yang dikaitkan dengan perjanjian distribution dengan Kanger

China to supply 1 billion vaccine doses overseas by year end - Global Times

Source: https://www.theedgemarkets.com/article/china-supply-1-billion-vaccine-doses-overseas-year-end-global-times#.YLoaa4Qn1UM.telegram

My remarks:
1. Wuhan Institute of Biological Products saya rasa satu lagi vaksin oleh Sinopharm, Sinopharm / WIBP2. WIBP tu ialah Wuhan Institute of Biological Products.

2. Yang dah lulus 7 Mei tu, Vaksin Sinopharm / BIBP1 vaccine was developed through a collaboration between the Chinese Center for Disease Control and Prevention (CDC) and the Beijing Institute of Biological Products (BIBP)/China National Biotec Group Company Limited (CNBG).

3. Kedua-duanya melibatkan CNBG yang dikaitkan dengan perjanjian distribution dengan Kanger

SHAH ALAM - Tempoh penilaian permohonan lengkap bagi pendaftaran bersyarat untuk vaksin Covid-19 telah dipendekkan daripada 245 hari kepada 120 hari bekerja.

@Noobie. As stated in the company's report to Bursa and media, it should be as stated, It is Hunan Changde Medical Equipment Co., Ltd

@Noobie123.
Separate agreement on type of product to be signed between Sinopharm and Kanger. Where is it?
--------------------
I can't get any upadated info about this.
May be they not yet sign it.

But I think the signing detail about it not so material because the major agreement deal has been signed and announced @ KLSE.

@Noobie123.

Question 2. Is Sinopharm Changde Hunan is authorised for overseas export of Sinopharm. Are you sure Kanger signed with the right party? What type of operations does Changde Hunan really do?
---------------------

I am not sure about Sinopharm Hunan Changde Medical Co. Ltd. authorisation to export of Sinopharm vaccine.

But, the existence of this company and its relation with Sinopharm Group of company can be verified as follows:

Sinopharm, Hunan Changde Medical is a company incorporated in the People Republic of China (“PRC”) with a business address at No. 22, 3rd Floor, Zone A, Tower 2, Long Mei Street, Changde Economic and Technological Development Changde, Hunan Province, PRC. Sinopharm Hunan Changde is principally engaged in sale of medical supplies and equipment, and is part of Sinopharm Group, which is a large Chinese state-owned healthcare group.

(Note: The Sinopharm Group Hunan Changde Medical Co. Ltd. existence can be checked @ this web link: http://www.info-clipper.com/en/company/china/sinopharm-holding-hunan-changde-medical-equipment-co-ltd.cnd9657ed.html ).

And also, there is an evidence base on the report that,
"Kanger will receive 10,000 doses of a Covid-19 vaccine developed by state-owned China National Pharmaceutical Group Corp Sinopharm) for trial purposes"

(Note: https://www.theedgemarkets.com/article/kanger-receive-10000-doses-sinopharm-covid19-vaccine%C2%A0-may-trial-purposes )


My conclusion is Sinopharm Hunan Changde Medical Co. Ltd. is exist and Kanger suppose to import the Sinopharm vaccine via Sinopharm Hunan Changde Medical Co. Ltd.'s dealearship.

Question 1. Sinopharm got 2 types of vaccine Wuhan & Bejing. Which vaccine are we talking about. WHO approved which vaccine? Did Kanger sign for the approved type of vaccine?
------------------------

Kanger had entered a collaboration agreement with China-based Sinopharm Group Hunan Changde Medical Co Ltd (Sinopharm Group) for the distribution of Covid-19 vaccines developed by China National Biotech Group Company (CNBG) in Malaysia.

Additional information related:

1. China National Biotec Group (CNBG), is a subsidiary of China National Pharmaceutical Group Corporation (SINOPHARM).

2. Sinopharm vaccine Sinopharm / BIBP1 or SARS-CoV-2 - BIBP1 was developed through a collaboration between the Chinese Center for Disease Control and Prevention (CDC) and the Beijing Institute of Biological Products (BIBP)/China National Biotec Group Company Limited (CNBG).

3. CNBG is also developing another vaccine, Sinopharm / WIBP1 or SARS-CoV-2 - WIBP1.

4. The Sinopharm / BIBP1 vaccine has been approved by WHO on 7 May 2021, where as Sinopharm / WIBP1 is still under its assessment process by WHO.


As a conclusion, BOTH OF THE VACCINES ARE RELATED TO CNBC, AND CAN BE DISTRIBUTED BY CANGDE MEDICAL CO. LTD. But I thinks its better for Kanger to focus more on currently approve vaccine, it is Sinopharm / BIBP1.

Noobie123. I look up and look down...still cannot find the word "SOLE DISTRIBUTOR. "

-----------------------
Yes there is a discrepancy there:
1. Based on announcent @ KLSE.
Just stated as distributor

Source: https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3092107

2. Based on MSN news report.
Under the agreement, Sinopharm Group has appointed KIB as the sole distributor for the
vaccines, medical devices and products in Malaysia.

Source: https://www.msn.com/en-my/news/national/kanger-sinopharm-inks-agreement-for-covid-19-vaccine-distribution-in-malaysia/ar-BB19x0Lr

1. Perjanjian sebagai SOLE DISTRIBUTOR yang dilantik untuk 3 tahun oleh Sinopharm dah ada - SETTLE

Sumber: https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3092107

2. MOU untuk wakil distributor bagi pihak Kanger dah ada iaitu Zuellig Pharma - SETTLE

Sumber:
1. https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3154098
2. https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3137884

Nota: Kanger will collaborate with ZP to facilitate the import, warehousing, and
distribution of Covid-19 vaccines in Malaysia. Kanger will receive 10,000 doses of a Covid-19 vaccine developed by state-owned China National Pharmaceutical Group Corp (Sinopharm) for trial purposes. The first batch of vaccines is expected to arrive in Malaysia on May 2021).


3. MOU untuk saluran jualan vaksin ke kilinik swasta di Malaysia dah ada iaitu KSport - SETTLE

Sumber:

1. https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3154097
2. https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3137884

SEKARANG TUNGGU UNTUK PROSES APPROVAL OLEH KERAJAAN DAN NPRA SAHAJA.

1. Perjanjian sebagai SOLE DISTRIBUTOR yang dilantik untuk 3 tahun oleh Sinopharm dah ada - SETTLE

Sumber: https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3092107

2. MOU untuk wakil distributor bagi pihak Kanger dah ada iaitu Zuellig Pharma - SETTLE

Sumber:
1. https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3154098
2. https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3137884

Nota: Kanger will collaborate with ZP to facilitate the import, warehousing, and
distribution of Covid-19 vaccines in Malaysia. Kanger will receive 10,000 doses of a Covid-19 vaccine developed by state-owned China National Pharmaceutical Group Corp (Sinopharm) for trial purposes. The first batch of vaccines is expected to arrive in Malaysia on May 2021).


3. MOU untuk saluran jualan vaksin ke kilinik swasta di Malaysia dah ada iaitu KSport - SETTLE

Sumber:

1. https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3154097
2. https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3137884

SEKARANG TUNGGU UNTUK PROSES APPROVAL OLEH KERAJAAN DAN NPRA SAHAJA.

@Noobie123. So where is this agreement? Not disclosed yet to Bursa?
---------------------------------
SILA RUJUK SINI WAHAI NO NEWBIE... HE HE

OTHERS Kanger International Berhad ("Kanger" or "Company") and its subsidiary companies ("Group") - Collaboration Agreement with Sinopharm Group Hunan Changde Medical Co. Ltd.

Source: https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3092107

@nOOBIE123.

2. Kanger had entered a collaboration agreement with China-based Sinopharm Group Hunan Changde Medical Co Ltd (Sinopharm Group) for the distribution of Covid-19 vaccines developed by China National Biotech Group Company (CNBG) in Malaysia.

Under the agreement, Sinopharm Group has appointed KIB as the SOLE DISTRIBUTOR for the vaccines, medical devices and products in Malaysia. KIB will also undertake the marketing and promotion of Sinopharm Group's products in Malaysia, however, both parties will sign a separate agreement in regards to specific product category, price, purchase price and payment method.

(Remarks: This agreement shall take effect for a period of three years effective from 25 September 2020 until 24 September 2023)

Source: https://www.msn.com/en-my/news/national/kanger-sinopharm-inks-agreement-for-covid-19-vaccine-distribution-in-malaysia/ar-BB19x0Lr

@TPC007. Noted. The 007 agent is here.
Probably the Nexgram's competitor's agent. He He

Kalau dia tak ambil kemudahan untuk sebulan postpone, sepatutnya keluar akhir bulan ini.

@zzzzzzz. Tengok nanti prestasi QR3 2021.

Adakah janji BOD Nexgram adalah betul atau TIN KOSONG. He He

Based on QR2 2021, revenue increased 157% due to mainly attributable from manufacturing of MEDICAL PLASTIC PRODUCTS, providing Tracvirus Covid-19 related services and distribution of Covid-19 test kits.

**** Tak tahulah sumbangan medical plastic products tu melibatkan atau tidak vaccine bootle oleh Arita Plastic

UNTUK PROJEK SUBKONTRAK LEBUHRAYA

COMMENCEMENT AND COMPLETION DATE
The Project had commenced on 16 July 2020 and to be completed on or not later than 15 August 2022, being the completion date for the Project as provided under the Letter of Award.

FINANCIAL EFFECTS OF THE JVA
This JVA is not expected to have any material effect on the earnings per share, net assets per share, share capital and substantial shareholders’ shareholding of the Company for the financial year ending 31 July 2021. However, it is expected that the JVA will contribute positively to the future revenue of the Group.

** Kalau tidak ada apa-apa masalah, sepatutnya highway sub conctract tu jalan, telah dimulakan pada 16 Julai 2020 lagi,

zzzzzzz Arita sekarang siapa punya nx kah????
-------------
Ya. 61%

@satriahijau. Itu pandangan yang rasional dari awak. Awak lebih kenal Kanger dari saya yang lebih kurang dua minggu baharu mengenali Kanger melalui rujukan google semata-mata.

Saya sendiri pun bukan 100% percaya. Tapi dari segi MOU fasal vaksin ni sahaja (YA),

IANYA SAYA PERCAYA 100% BERJAYA ATAU TIDAK MOU AKAN BERGANTUNG KEPADA BERJAYA ATAU TIDAK KANGER MENDAPATKAN KELULUSAN KERAJAAN DAN NPRA UNTUK MENGEDARKAN VAKSIN SINOPHARM DI MALAYSIA.

GAGAL DAPAT KELULUSAN, GAGAL LAH SEMUA MOU BERKAITAN VAKSIN.
LAGI SEKALI LAH JADI MOU TIPU.

@satriahijau.
(kalau kanger benar dan betul2 terlibat dgn vaksin Sinopharm).
---------------------
Saya hanya cuba bergantung kepada ini untuk percaya:

Report 1: The Sinopharm Covid-19 vaccine is in the process of being approved in Malaysia, including by the National Pharmaceutical Regulatory Agency (NPRA).

“We will ensure that we obtain the required approvals from relevant authorities before we commence distribution of the Sinopharm vaccines.

“Once approvals are obtained, the people of Sabah will be one of the early recipients of the Sinopharm vaccines,” Kuah said.

(Source: https://www.theedgemarkets.com/article/kanger-signs-mou-sabah-govt-procure-chinas-sinopharm-covid19-vaccines).

Report 2: Kanger International executive director Steven Kuah told reporters that, “the process of registering the Sinopharm vaccine (with NPRA) has started and we hope to receive some good news on its approval soon.”

(Source: https://www.freemalaysiatoday.com/category/nation/2021/05/27/sabah-signs-mou-with-private-firm-to-obtain-sinopharm-vaccine/ )

UNTUK KETERANGAN LEBIH LANJUT BOLEH BACA ATAU BACA LAGI SEKALI ARTIKEL BLOG SAYA MELALUI LINK:

https://klse.i3investor.com/blogs/httpsklsei3investorcomM/2021-05-29-story-h1565953920-Kanger_017_The_Bamboo_Flooring_And_Related_Products_Company_Is_Trying_H.jsp

Khairy macam memberi tahu syarat bahawa lulus WHO penting. Dan NPRA mungkin lebih senang lulus jika vaksin tersebut lulus WHO. KAWAN-KAWAN ADA PANDANGAN LAIN?
Untuk dibincang secara rasional. Bukan sekadar idea HATER atau NAYSAYER,

Report 6: The states are free to negotiate with drug makers Moderna and Sinopharm, whose vaccines have been approved by the World Health Organization . Khairy said that as long as the vaccines have been given the green light by the National Pharmaceutical Regulatory Agency, the states are free to procure them.

(Source: https://www.freemalaysiatoday.com/category/nation/2021/06/03/state-govts-free-to-purchase-moderna-sinopharm-vaccines/ )

Sama ramai promoter dengan naysayer.
Dalam setiap group thread kebanyakan kaunter kedua-duanya ada. He He

Kih Kih Kih. Kesian telor nanti nak letak mana?

wow. Hopefully

Dccy720714 Sinopharm has been approved by NPRA , state govn are free to purchase it
---------------------------
PLEASE GIVE US PROOF. IS IT ANY EVIDENCE/ LINK OF INFORMATION?

Kanger International executive director Steven Kuah told reporters that, “the process of registering the Sinopharm vaccine (with NPRA) has started and we hope to receive some good news on its approval soon.”

The Sinopharm Covid-19 vaccine is in the process of being approved in Malaysia, including by the National Pharmaceutical Regulatory Agency (NPRA).

@TPC007. OOOO. Faham. Boom sudah mari. Agen sudah mari... He He

and.. also awaiting for new development about it business to MAIN WAYANG. He He

Tunggu QR3 end of this month. Nexgram with an accumulated profit as all accumulated losses elimated by the capital reduction exercise, and hopefully the current QR3 also will show profit.

Noobie123 Just check the corporate history. How many MOUs had been signed? And how many actually became contract? Then make own judgement.
---------------------------------
RI successful then the process of acquiring 51% equity interest in Sung Master will be a success.

Sung Master is a company principally involved in the sales and trading of building materials, which include, timber flooring, tiles, bulk cement, concrete, locksets and sanitary ware.

The acquisition potential , amongst others, could give an expansion of the existing business activities of Kanger specifically in the manufacturing and trading of building materials i.e. bamboo flooring and related products.

https://klse.i3investor.com/blogs/unspokerules/2021-06-03-story-h1566017345-RIGHTS_ISSUE_WITH_WARRANTS_APPROVED_TIME_TO_FLY_SOON.jsp

@Peace99. Thanks. The blog article has been corrected. Sorry.

@Luckybull. Dah baca.

In a statement on Tuesday, it said the supply of the vaccine is subject to the approval of the vaccine by the Drug Control Authority of Malaysia, as well as other terms and conditions of supply.

MZM2511 Luckybull Spunik duopharma sudah approved boleh Masuk Malaysia. Sinopharm tengah berak?
-----------------
Sputnik V pun belum finalize approve sehingga 28 Mei 2021. Hari ini tak tahulah saya, mungkin sudah approved. Sila lihat blog untuk dapatkan status pendaftaran setiap calon vaksin covid-19 di Malaysia.

The process just been started on 30 April 2021

OTHERS NEXGRAM HOLDINGS BERHAD - APPOINTMENT OF AUDITORS Source: https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3163233

@Noobie123. It's okay. Investment is full of risks and thorns. He He

Okay. Thanks. I'm a newbie here.

Yang lebih bahaya kalau-kalau ada ular yang dah tukar dari pro kepada kon dan sebaliknya anti ular dan tukar dari kon kepada pro --- yang berlaku disebabkan atas kepentingan sendiri.

Ini bahaya. Nihhhh.

Ular jadian pun boleh muncul. Begitu juga dengan anti ular pun kadang-kadang ada pengganti.
Analisis dan kepentingan terhadap sesuatu saham berbeza antara individu yang terlibat menyebabkan penilaian yang berbeza, SPAM yang dibuat berbeza antara yang pro dan kon.

@MatDangz. Tak tahu lah. Semua terpulang kepada roti canai separuh masak... He He

NPRA looking into more vaccine registrations, to go for private market (19 May 2021)

Source: https://www.malaysiakini.com/news/575232

Noobie123 Kanger dah submit application? Bila?
------------------------
Hanya maklumat di bawah ini yang saya boleh dapat.

Dikatakan proses pendaftaran "TELAH DIMULAKAN dan BERHARAP AKAN MENERIMA BERITA BAIK BERKENAANNYA SECEPAT MUNGKIN." "

Itu pun maklumat ini hanya akan berguna untuk pihak yang ada sedikit kepercayaan apa yang dilaporkan oleh pihak Kanger. Yang tak percaya tu, TAK Perlu BACA PUN. He. He

Sabah finance ministry permanent secretary Rusdin Riman and Kanger International executive director Steven Kuah signed the MoU at the Sabah state administrative centre, here, today.

Kuah told reporters that the company would obtain approval from Putrajaya through the National Pharmaceutical Regulatory Agency (NPRA) before bringing the supply into Sabah.

“The process of registering the Sinopharm vaccine (with NPRA) has started and we hope to receive some good news on its approval soon.

Source: https://www.freemalaysiatoday.com/category/nation/2021/05/27/sabah-signs-mou-with-private-firm-to-obtain-sinopharm-vaccine/

@BilisMasin. Kalau macam tu, ada orang mahu tunggu beli @7 sen.
Mungkin BilisMasin akan jual @7 sen hari ini......

@weirdvilante. From this website.

https://www.bursamalaysia.com/market_information/announcements/company_announcement?company=7036
-------------------------------------

Bornoil reported their gold mining production figures started on May 2015 up to May 2019.

1. Bornoil reported their gold mining production figures started based an announcement dated 25 May 2015.
Source: https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=2582775

2. The last gold mining production figures reported based an announcement dated 29 May 2019.
Source: https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=2958336

Next, BOD Hj Mazru would converted his ICPS, and he individually could hold maximum up to 23% of share holding. It's only in my dream. He He

@BilisMasin. Maaf. Sekali lagi saya repost pandangan saya.
---------------------
Ini pun baru saya buat pertama kali masuk kaunter ni minggu lepas.

Apa-apa maklumat yang saya beri jangan percaya secara terus. Teliti SAHIH ke tidak, ada bukti ke atau tidak. Kalau tak setuju boleh komen balas atau terus tak percaya, buat don't know saja.

Tidak sekali-kali nak ajak semua masuk sekali dalam lubuk buaya. Melabur adalah keputusan sendiri. Risiko tanggung sendiri...

Kita pelabur runcit yang bukan insider hanya peroleh sedikit maklumat sahaja. Bakinya jadi NUJUM PAK BELALANG.

Itulah kadang-kadang selalu kena "makan pucuk" atau "sewa kondo tingkat tertinggi."

APA-APA PUN TAYOR...

@8dragon. Pegangan BOD tak sampai pun 5% pegangan saham. Nak privatise ke?
Belajar dulu ilmu akaun dan Akta Syarikat, wahai SISTER!!!

@BilisMasin. Sorry. Kalau macam tu you are a "SAINT". Titik. Isu ini dari saya. Maaf lagi sekali.